Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$1.46 | -$1.46 | -$1.46 |
Q2 2024 | 1 | $10.82 | $10.82 | $10.82 |
Connect Biopharma Holdings Limited last posted its earnings results on Thursday, September 5th, 2024. The company reported $0.00947 earnings per share for the quarter, topping analysts' consensus estimates of $-0.02808 by $0.03755. The company had revenue of 12.06 M for the quarter and had revenue of 0 for the year. Connect Biopharma Holdings Limited has generated $-1 earnings per share over the last year ($-1.08 diluted earnings per share) and currently has a price-to-earnings ratio of 7.02. Connect Biopharma Holdings Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
06/28/2024 | Q2 2024 | $0.07 | $1.10 B | $12.06 M | ||
03/30/2024 | Q1 2024 | $0.07 | $12.06 M | |||
04/16/2024 | Q4 2023 | -$0.03 | -$0.27 | -0.24 | $0 | |
09/29/2023 | Q3 2023 | -$0.28 | $0 | |||
06/28/2023 | Q2 2023 | -$0.56 | $0 | |||
03/30/2023 | Q1 2023 | -$0.28 | $0 | |||
04/11/2023 | Q4 2022 | -$3.58 | -$1.03 | 2.55 | $0 | |
09/29/2022 | Q3 2022 | -$0.56 | $0 | |||
06/28/2022 | Q2 2022 | -$1.12 | $0 | |||
03/30/2022 | Q1 2022 | -$4.38 | -$0.57 | 3.81 | $0 | |
03/31/2022 | Q4 2021 | -$4.38 | -$1.05 | 3.33 | $0 | |
08/31/2021 | Q3 2021 | -$2.36 | -$0.49 | 1.87 | $0 | |
08/31/2021 | Q2 2021 | -$2.36 | -$3.10 | -0.74 | $0 | |
03/30/2021 | Q1 2021 | -$1.53 | $0 | |||
12/30/2020 | Q4 2020 | -$3.16 | $0 | |||
09/29/2020 | Q3 2020 | -$3.03 | $0 | |||
06/29/2020 | Q2 2020 | -$0.31 | $0 | |||
03/30/2020 | Q1 2020 | -$0.31 | $0 |
Connect Biopharma Holdings Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based off last year's report dates.
In the previous quarter, Connect Biopharma Holdings Limited (:CNTB) reported $0.00947 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.02808 by $0.03755.
The conference call for Connect Biopharma Holdings Limited's latest earnings report can be listened to online.
The conference call transcript for Connect Biopharma Holdings Limited's latest earnings report can be read online.
Connect Biopharma Holdings Limited (:CNTB) has a recorded net income of $0. Connect Biopharma Holdings Limited has generated $-1.08 earnings per share over the last four quarters.
Connect Biopharma Holdings Limited (:CNTB) has a price-to-earnings ratio of 7.02 and price/earnings-to-growth ratio is 0.12.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED